0001209191-13-016611.txt : 20130314
0001209191-13-016611.hdr.sgml : 20130314
20130314175254
ACCESSION NUMBER: 0001209191-13-016611
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130313
FILED AS OF DATE: 20130314
DATE AS OF CHANGE: 20130314
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TURNER JOSEPH L
CENTRAL INDEX KEY: 0001266129
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 13691540
MAIL ADDRESS:
STREET 1: 10505 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-03-13
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001266129
TURNER JOSEPH L
C/O CORCEPT THERAPEUTICS
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
1
0
0
0
Common stock
2013-03-13
4
P
0
1500
2.00
A
1500
D
Common stock
2013-03-14
4
P
0
8500
2.0078
A
10000
D
/s/ Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated attorney-in-fact
2013-03-14